<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002307'>Drooling</z:hpo> is common in patients with <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">neurological disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, botulinum toxin type B has been shown to be effective in the treatment of <z:hpo ids='HP_0002307'>drooling</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The authors present a unique case of a 57-year-old man with a history of a brainstem <z:hpo ids='HP_0001297'>stroke</z:hpo> and severe <z:hpo ids='HP_0002307'>drooling</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The patient's parotid and submandibular glands were injected under ultra-sound guidance with botulinum toxin type B </plain></SENT>
<SENT sid="4" pm="."><plain>Saliva was collected and quantified before and after the injections by 2 different collection methods: suctioning and dental rolls </plain></SENT>
<SENT sid="5" pm="."><plain>Total saliva production decreased by 23.8% after injection of the parotid glands and by 85.8% after submandibular injection compared to the preinjection level </plain></SENT>
<SENT sid="6" pm="."><plain>The 2 methods demonstrated similar results </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, the patient experienced less <z:hpo ids='HP_0002307'>drooling</z:hpo> and increased participation in therapies without any side effects </plain></SENT>
<SENT sid="8" pm="."><plain>This case demonstrates that saliva secretion and <z:hpo ids='HP_0002307'>drooling</z:hpo> can effectively be treated by injections of botulinum toxin type B into the salivary glands </plain></SENT>
</text></document>